Marsha Alpert Chandler, a director of Biocept, recently acquired 4,545 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from March 04 to October 19, 2016. Chandler now owns 6,905 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Chandler operates out of San Diego, CA. Some additional info was provided as follows:
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,333 fewer shares with respect to these shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 3,385 fewer shares with respect to thes
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Registration statement under Securities Act of 1933 - Aug. 18, 2017
Bin Li just provided an update on activist position in Biocept - Aug. 17, 2017
Major owner of Biocept just declared owning 3,147,667 shares of Biocept - Aug. 17, 2017
Notice of Exempt Offering of Securities, item 06b - Aug. 14, 2017
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Aug. 14, 2017